For research use only. Not for therapeutic Use.
2-Aminopurine-O-Ph-NHCO-C3-COOH hydrochloride is the acid form in the previous step of the final product 2-Aminopurine-O-Ph-NHCO-C3-NHS ester (HY-143336)[1].
Catalog Number | I040228 |
Synonyms | 5-[[4-[(2-amino-7H-purin-6-yl)oxymethyl]phenyl]methylamino]-5-oxopentanoic acid;hydrochloride |
Molecular Formula | C18H21ClN6O4 |
Purity | ≥95% |
InChI | InChI=1S/C18H20N6O4.ClH/c19-18-23-16-15(21-10-22-16)17(24-18)28-9-12-6-4-11(5-7-12)8-20-13(25)2-1-3-14(26)27;/h4-7,10H,1-3,8-9H2,(H,20,25)(H,26,27)(H3,19,21,22,23,24);1H |
InChIKey | RYGZKXIKFUHQNI-UHFFFAOYSA-N |
SMILES | C1=CC(=CC=C1CNC(=O)CCCC(=O)O)COC2=NC(=NC3=C2NC=N3)N.Cl |
Reference | [1]. Heppenstall, et al. Modified viral particles for gene therapy. Patent. WO2022101363. |